-
1
-
-
33846701592
-
Cumulative cost pattern comparison of prostate cancer treatments
-
Wilson LS, Tesoro R, Elkin EP, Sadetsky N, Broering JM, Latini DM, DuChane J, Mody RR, Carroll PR. Cumulative cost pattern comparison of prostate cancer treatments. Cancer 2007;109(3): 518-527.
-
(2007)
Cancer
, vol.109
, Issue.3
, pp. 518-527
-
-
Wilson, L.S.1
Tesoro, R.2
Elkin, E.P.3
Sadetsky, N.4
Broering, J.M.5
Latini, D.M.6
DuChane, J.7
Mody, R.R.8
Carroll, P.R.9
-
2
-
-
34548515743
-
Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications
-
Krupski TL, Foley KA, Baser O, Long S, Macarios D, Litwin MS. Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications. J Urol 2007;178(4 Pt 1):1423-1428.
-
(2007)
J Urol
, vol.178
, Issue.4 PART 1
, pp. 1423-1428
-
-
Krupski, T.L.1
Foley, K.A.2
Baser, O.3
Long, S.4
Macarios, D.5
Litwin, M.S.6
-
3
-
-
0037299782
-
Side effects of androgen deprivation therapy: Monitoring and minimizing toxicity
-
Higano CS. Side effects of androgen deprivation therapy: Monitoring and minimizing toxicity. Urology 2003;61(2 Suppl 1):32-38.
-
(2003)
Urology
, vol.61
, Issue.2 SUPPL. 1
, pp. 32-38
-
-
Higano, C.S.1
-
4
-
-
0033526309
-
Natural history of progression after PSA elevation following radical prostatectomy
-
Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999;281(17):1591-1597.
-
(1999)
JAMA
, vol.281
, Issue.17
, pp. 1591-1597
-
-
Pound, C.R.1
Partin, A.W.2
Eisenberger, M.A.3
Chan, D.W.4
Pearson, J.D.5
Walsh, P.C.6
-
5
-
-
33646027312
-
Intermittent androgen deprivation: Clinical experience and practical applications
-
vi
-
Wright JL, Higano CS, Lin DW. Intermittent androgen deprivation: Clinical experience and practical applications. Urol Clin North Am 2006;33(2):167-179, vi.
-
(2006)
Urol Clin North Am
, vol.33
, Issue.2
, pp. 167-179
-
-
Wright, J.L.1
Higano, C.S.2
Lin, D.W.3
-
6
-
-
0025684708
-
Loss of androgen dependence is associated with an increase in tumorigenic stem cells and resistance to cell-death genes
-
Rennie PS, Bruchovsky N, Coldman AJ. Loss of androgen dependence is associated with an increase in tumorigenic stem cells and resistance to cell-death genes. J Steroid Biochem Mol Biol 1990;37(6):843-847.
-
(1990)
J Steroid Biochem Mol Biol
, vol.37
, Issue.6
, pp. 843-847
-
-
Rennie, P.S.1
Bruchovsky, N.2
Coldman, A.J.3
-
7
-
-
0027416692
-
Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen
-
Akakura K, Bruchovsky N, Goldenberg SL, Rennie PS, Buckley AR, Sullivan LD. Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen. Cancer 1993;71(9):2782-2790.
-
(1993)
Cancer
, vol.71
, Issue.9
, pp. 2782-2790
-
-
Akakura, K.1
Bruchovsky, N.2
Goldenberg, S.L.3
Rennie, P.S.4
Buckley, A.R.5
Sullivan, L.D.6
-
8
-
-
0030152008
-
Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model
-
Sato N, Gleave ME, Bruchovsky N, Rennie PS, Goldenberg SL, Lange PH, Sullivan LD. Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model. J Steroid Biochem Mol Biol 1996;58(2):139-146.
-
(1996)
J Steroid Biochem Mol Biol
, vol.58
, Issue.2
, pp. 139-146
-
-
Sato, N.1
Gleave, M.E.2
Bruchovsky, N.3
Rennie, P.S.4
Goldenberg, S.L.5
Lange, P.H.6
Sullivan, L.D.7
-
9
-
-
0142228727
-
Intermittent maximal androgen blockade in patients with metastatic prostate cancer: An EORTC feasibility study
-
Albrecht W, Collette L, Fava C, Kariakine OB, Whelan P, Studer UE, De Reijke TM, Kil PJ, Rea LA. Intermittent maximal androgen blockade in patients with metastatic prostate cancer: An EORTC feasibility study. Eur Urol 2003;44(5):505-511.
-
(2003)
Eur Urol
, vol.44
, Issue.5
, pp. 505-511
-
-
Albrecht, W.1
Collette, L.2
Fava, C.3
Kariakine, O.B.4
Whelan, P.5
Studer, U.E.6
De Reijke, T.M.7
Kil, P.J.8
Rea, L.A.9
-
10
-
-
26444573085
-
Intermittent androgen castration: A biological reality during intermittent treatment in metastatic prostate cancer?
-
Mottet N, Lucas C, Sene E, Avances C, Maubach L, Wolff JM. Intermittent androgen castration: A biological reality during intermittent treatment in metastatic prostate cancer? Urol Int 2005;75(3):204-208.
-
(2005)
Urol Int
, vol.75
, Issue.3
, pp. 204-208
-
-
Mottet, N.1
Lucas, C.2
Sene, E.3
Avances, C.4
Maubach, L.5
Wolff, J.M.6
-
11
-
-
34548443017
-
The role of intermittent androgen deprivation in prostate cancer
-
Boccon-Gibod L, Hammerer P, Madersbacher S, Mottet N, Prayer-Galetti T, Tunn U. The role of intermittent androgen deprivation in prostate cancer. BJU Int 2007;100(4):738-743.
-
(2007)
BJU Int
, vol.100
, Issue.4
, pp. 738-743
-
-
Boccon-Gibod, L.1
Hammerer, P.2
Madersbacher, S.3
Mottet, N.4
Prayer-Galetti, T.5
Tunn, U.6
-
12
-
-
0034743524
-
Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone
-
Dadras SS, Cai X, Abasolo I, Wang Z. Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone. Gene Expr 2001;9(4-5):183-194.
-
(2001)
Gene Expr
, vol.9
, Issue.4-5
, pp. 183-194
-
-
Dadras, S.S.1
Cai, X.2
Abasolo, I.3
Wang, Z.4
-
13
-
-
0041633811
-
Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer
-
Xiao W, Zhang Q, Jiang F, Pins M, Kozlowski JM, Wang Z. Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer. Cancer Res 2003; 63(15):4698-4704.
-
(2003)
Cancer Res
, vol.63
, Issue.15
, pp. 4698-4704
-
-
Xiao, W.1
Zhang, Q.2
Jiang, F.3
Pins, M.4
Kozlowski, J.M.5
Wang, Z.6
-
14
-
-
1642546368
-
Identification and characterization of an androgen-responsive gene encoding an aci-reductone dioxygenase-like protein in the rat prostate
-
Oram S, Jiang F, Cai X, Haleem R, Dincer Z, Wang Z. Identification and characterization of an androgen-responsive gene encoding an aci-reductone dioxygenase-like protein in the rat prostate. Endocrinology 2004;145(4):1933- 1942.
-
(2004)
Endocrinology
, vol.145
, Issue.4
, pp. 1933-1942
-
-
Oram, S.1
Jiang, F.2
Cai, X.3
Haleem, R.4
Dincer, Z.5
Wang, Z.6
-
15
-
-
0037474143
-
Over-expression of adrenomedullin gene markedly inhibits proliferation of PC3 prostate cancer cells in vitro and in vivo
-
Abasolo I, Yang L, Haleem R, Xiao W, Pio R, Cuttitta F, Montuenga LM, Kozlowski JM, Calvo A, Wang Z. Over-expression of adrenomedullin gene markedly inhibits proliferation of PC3 prostate cancer cells in vitro and in vivo. Mol Cell Endocrinol 2003;199(1-2):179-187.
-
(2003)
Mol Cell Endocrinol
, vol.199
, Issue.1-2
, pp. 179-187
-
-
Abasolo, I.1
Yang, L.2
Haleem, R.3
Xiao, W.4
Pio, R.5
Cuttitta, F.6
Montuenga, L.M.7
Kozlowski, J.M.8
Calvo, A.9
Wang, Z.10
-
16
-
-
33645341444
-
Enhancement of intermittent androgen ablation by "off-cycle" maintenance with finasteride in LNCaP prostate cancer xenograft model
-
Eggener SE, Stern JA, Jain PM, Oram S, Ai J, Cai X, Roehl KA, Wang Z. Enhancement of intermittent androgen ablation by "off-cycle" maintenance with finasteride in LNCaP prostate cancer xenograft model. Prostate 2006;66(5):495-502.
-
(2006)
Prostate
, vol.66
, Issue.5
, pp. 495-502
-
-
Eggener, S.E.1
Stern, J.A.2
Jain, P.M.3
Oram, S.4
Ai, J.5
Cai, X.6
Roehl, K.A.7
Wang, Z.8
-
17
-
-
33645970181
-
Intermittent use of testosterone inactivating pharmaceuticals using finasteride prolongs the time off period
-
Scholz MC, Jennrich RI, Strum SB, Johnson HJ, Guess BW, Lam RY. Intermittent use of testosterone inactivating pharmaceuticals using finasteride prolongs the time off period. J Urol 2006; 175(5):1673-1678.
-
(2006)
J Urol
, vol.175
, Issue.5
, pp. 1673-1678
-
-
Scholz, M.C.1
Jennrich, R.I.2
Strum, S.B.3
Johnson, H.J.4
Guess, B.W.5
Lam, R.Y.6
|